• Topics

  • Formats

Organiser: PM Society

At the PM Society Digital Interest Group (DIG), we set out to explore the role of AI in pharma marketing—not just by discussing it but by using AI to help write the very articles we were producing. This was far more than a writing exercise; it was an experiment in collaboration between human expertise and machine intelligence.

We had several questions that we wanted to answer:

(i) Could AI make the writing process faster?

(ii) Could it generate insightful, high-quality content?

(iii) Could it free up human writers to focus on creativity and strategy rather than mechanics?

The answer, as we discovered, was both yes and no. AI proved to be a powerful co-pilot, accelerating our workflow and helping us organise our thoughts. But it also had clear limitations, requiring careful human oversight to ensure accuracy, quality, and industry relevance.

This is the story of how we created our recent three-part AI-driven article series, what we learned on the journey, and what it could mean for the future of AI-assisted content creation.

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?